Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Page 1
Ref. MDA/2005/063
Issued: 28 November 2005
| IMMEDIATE ACTION |  |
| ACTION | |
| UPDATE | |
| INFORMATION REQUEST |
| Further Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEVICE: Lancing devices - including Roche Accu-Chek Softclix, Softclix II, Softclix Plus and Multiclix lancing devices. |
|||||||||||||
|
PROBLEM: |
> |
||||||||||||
| ACTION BY: All healthcare and care workers involved in the purchase, supply, provision or use of lancing devices. |
|||||||||||||
| ACTION: When testing multiple patients, healthcare and care workers should not use single patient lancing devices such as the Roche Accu-Chek Softclix, Softclix II, Softclix Plus or Multiclix lancing devices to obtain blood samples. When obtaining blood samples from more than one patient healthcare and care workers must ensure that the lancing device that they use is intended for this purpose. |
> |
||||||||||||
|
DISTRIBUTED to:
* via CE Bulletin |
> |
||||||||||||
|
CONTACTS: |
> |
> Further information supplied in the following pages.
MDA/2005/063 - Lancing devices - including Roche Accu-Chek Softclix, Softclix II, Softclix Plus and Multiclix lancing devices. 
